Media index
Research in thepublic conversation.
Selected reporting and public-facing coverage that quotes, cites or features my work across emerging infections, public health research and community resilience.
Browse the coverage ↓Last updated ·
Scope and organization
Media coverage and public engagement.
This page documents selected coverage of my research and public-health work. Articles quoting me directly are distinguished from subsequent media pickup, with separate sections for public engagement and reporting on published research. Select any title to view a two-sentence summary and source link.
Directly quoted
Two articles that quote me directly on emerging pathogens and pandemic preparedness. Select a title to view a summary.
Reporting from a WHO R&D Blueprint meeting, this article examines which viruses, bacteria and drug-resistant organisms might constitute “Pathogen X” and what preparedness would require. It quotes Dr. Chatterjee on zoonotic spillover risk and the need for stronger global governance and One Health surveillance embedded in existing public health systems.
This feature examines why a future Disease X is likely to emerge through zoonotic spillover and how prototype vaccines, event-based surveillance and sustained research investment could reduce risk. Dr. Chatterjee discusses the warning provided by H5N1 cases, the importance of detecting spillover early and the role of One Health in coordinating human, animal and environmental health.
Wider coverage
Subsequent reporting that carried the Disease X discussion into wider public circulation.
This explainer defines Disease X as the WHO’s placeholder for an as-yet-unknown pathogen and reviews zoonotic, engineered and other possible origins. It reprises Dr. Chatterjee’s National Post comments that a Disease X event could be near and that recent H5N1 cases in Cambodia illustrate the need for preparedness.
Reporting on the WHO Director-General’s address to member states, this article considers preparations for pathogens with greater pandemic potential, including a pandemic accord and revisions to the International Health Regulations. It cites Dr. Chatterjee’s warning that Disease X may be close and notes expert expectations that the next pandemic could be zoonotic.
Mint explains the WHO’s priority-disease list and the use of “Disease X” to represent a pathogen not yet known to cause human disease. The article reproduces Dr. Chatterjee’s warning about the proximity of such an event and his reference to recent H5N1 cases in Cambodia.
Following the WHO Director-General’s call for renewed pandemic readiness, this article explains Disease X and its place among priority pathogens requiring research and surveillance. It cites Dr. Chatterjee’s H5N1 example while considering both zoonotic and human-engineered origins for a future threat.
This article reviews the Disease X concept, the likelihood of zoonotic spillover and the additional risk posed by deliberately or accidentally released pathogens. It repeats Dr. Chatterjee’s warning about H5N1 and emphasizes investment in surveillance, research and medical countermeasures.
The archived listing indicates that this article presented the WHO’s Disease X concept as a warning that a future pandemic could exceed COVID-19 in severity. Because the source page is no longer available, its detailed claims and any use of Dr. Chatterjee’s comments could not be independently verified.
The archived title indicates that this report discussed the WHO’s warning about an unknown pathogen capable of causing a severe future pandemic. Because the original page is unavailable, its full account and any attribution to Dr. Chatterjee could not be independently verified.
This article situates Disease X within the WHO’s priority list and discusses absent medical countermeasures, zoonotic spillover, engineered threats and the possible release of viruses from thawing environments. It repeats Dr. Chatterjee’s H5N1 example and emphasizes investment in surveillance and research.
This article introduces Disease X as an unknown pathogen that could emerge through animal-to-human spillover while also acknowledging engineered-pathogen risks. It cites Dr. Chatterjee’s view that recent H5N1 cases demonstrate why the next major infectious threat may arrive sooner than expected.
Public engagement
Research shared beyond journals and classrooms, in conversation with journalists and communities.
The Pulitzer Center’s event report describes Dr. Chatterjee’s global-health presentation on the compounded effects of COVID-19 among survivors of the Bhopal Gas Tragedy. It also highlights how affected communities organized mutual support while confronting overlapping environmental, health and justice-related crises.
Research in the news
Reporting that cites or discusses my published research and public health analysis.
This report covers a multi-institutional analysis of approximately 114,000 H1N1 cases and 8,543 deaths in India between 2010 and 2017, identifying Gujarat as most vulnerable for mortality and Delhi for morbidity. It names Pranab Chatterjee as a study author and summarizes the states accounting for the largest shares of reported cases and deaths.
This investigation uses government documents and internal meeting records to examine delays in India’s testing and surveillance strategy despite warnings from scientific advisers in February 2020. The current archived page does not visibly name Pranab Chatterjee or cite a specific paper by him, so its connection to his work should be confirmed before publication.